Drug Search Results
More Filters [+]

Tramiprosate

Alternative Names: tramiprosate, nc-758, nc758, nc 758
Latest Update: 2024-09-18
Latest Update Note: News Article

Product Description

Mechanisms of Action: GABA Partial Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Alzheon
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tramiprosate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Alzheimer Disease|Cerebral Amyloid Angiopathy

Phase 2: Cerebral Amyloid Angiopathy, Familial|Stroke|Cerebral Hemorrhage

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2006-006490-24

P3

Completed

Alzheimer Disease

2010-04-19

2004-003435-31

P3

Completed

Cerebral Amyloid Angiopathy|Alzheimer Disease

2007-12-14

CL-758003

P2

Completed

Cerebral Amyloid Angiopathy, Familial|Stroke|Cerebral Hemorrhage

None

CL-758017

P3

Unknown status

Alzheimer Disease

None

Recent News Events